2023 - Research.com Medicine in India Leader Award
2023 - Research.com Microbiology in India Leader Award
2022 - Research.com Microbiology in India Leader Award
His primary areas of study are Visceral leishmaniasis, Leishmaniasis, Immunology, Leishmania donovani and Miltefosine. His studies in Visceral leishmaniasis integrate themes in fields like Surgery, Internal medicine, Adverse effect, Combination therapy and Intensive care medicine. His work in Internal medicine addresses subjects such as Gastroenterology, which are connected to disciplines such as Chemotherapy, Nephrotoxicity, Oral administration and Indian visceral leishmaniasis.
His Leishmaniasis research is multidisciplinary, incorporating elements of Clinical trial, Pharmacology, Veterinary medicine, Leishmania and Drug resistance. The concepts of his Leishmania donovani study are interwoven with issues in Incidence, Virology, Amastigote, Microbiology and Molecular biology. His research in Miltefosine focuses on subjects like Dermatology, which are connected to Cutaneous leishmaniasis.
Shyam Sundar mainly investigates Visceral leishmaniasis, Leishmaniasis, Leishmania donovani, Immunology and Internal medicine. His Visceral leishmaniasis research is mostly focused on the topic Miltefosine. His study in Leishmaniasis is interdisciplinary in nature, drawing from both Chemotherapy, Serology, Direct agglutination test, Intensive care medicine and Veterinary medicine.
Shyam Sundar interconnects Molecular biology, Amastigote and Drug resistance, Microbiology in the investigation of issues within Leishmania donovani. His work carried out in the field of Immunology brings together such families of science as Peripheral blood mononuclear cell and Asymptomatic. His research combines Gastroenterology and Internal medicine.
His scientific interests lie mostly in Visceral leishmaniasis, Leishmania donovani, Leishmaniasis, Immunology and Leishmania. His study in the field of Miltefosine is also linked to topics like Indian subcontinent. His Leishmania donovani study combines topics in areas such as Immunity, Antigen, Microbiology, Intracellular and Pharmacology.
His Leishmaniasis research integrates issues from Xenodiagnosis, Intensive care medicine, Disease and Virology. The Leishmania study combines topics in areas such as Macrophage and Proteomics, Gene, Genome. His Internal medicine research is multidisciplinary, incorporating perspectives in Serology and Rapid diagnostic test.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Drug Resistance in Leishmaniasis
Simon L. Croft;Shyam Sundar;Alan H. Fairlamb.
Clinical Microbiology Reviews (2006)
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
François Chappuis;François Chappuis;Shyam Sundar;Asrat Hailu;Hashim Ghalib.
Nature Reviews Microbiology (2007)
Visceral leishmaniasis : current status of control, diagnosis, and treatment, and a proposed research and development agenda
Philippe J Guerin;Philippe J Guerin;Piero Olliaro;Piero Olliaro;Shyam Sundar;Marleen Boelaert.
Lancet Infectious Diseases (2002)
Oral Miltefosine for Indian Visceral Leishmaniasis
Shyam Sundar;T K Jha;C P Thakur;Juergen Engel.
The New England Journal of Medicine (2002)
Failure of Pentavalent Antimony in Visceral Leishmaniasis in India: Report from the Center of the Indian Epidemic
Shyam Sundar;Deepak K. More;Manoj K. Singh;Vijay P. Singh.
Clinical Infectious Diseases (2000)
Drug resistance in Indian visceral leishmaniasis.
Tropical Medicine & International Health (2001)
Laboratory Diagnosis of Visceral Leishmaniasis
Shyam Sundar;M. Rai.
Clinical and Vaccine Immunology (2002)
Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis.
T.K. Jha;Shyam Sundar;C.P. Thakur;Peter Bachmann.
The New England Journal of Medicine (1999)
Injectable paromomycin for Visceral leishmaniasis in India.
Shyam Sundar;T K Jha;Chandreshwar P Thakur;Prabhat K Sinha.
The New England Journal of Medicine (2007)
Evidence that the High Incidence of Treatment Failures in Indian Kala-Azar Is Due to the Emergence of Antimony-Resistant Strains of Leishmania donovani
Rosalia Lira;Shyam Sundar;A. Makharia;Richard Kenney.
The Journal of Infectious Diseases (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: